Metakosmos Listed Among TechConnect World 2023 Innovation Showcase Participants

Metakosmos was listed among the 2023 Innovation Showcase participants at TechConnect World.

TechConnect World is a technology commercialisation conference. Its Innovation Showcase surfaces early-stage technologies from universities, national laboratories and companies to an audience including corporate, government and investment participants.

WHAT WAS PRESENTED

The company was showing a spacesuit architecture with terrestrial applications. Metakosmos was registered in 2020 and built its position in stealth before launching publicly in 2022.

The position was that suit systems should be designed as multi-environment platforms from the outset, because the human physiology being protected does not change between environments even where the physics do.

OTHER 2023 ACTIVITY

Nomination in two categories at the Australian Space Awards. Participation in the NSW Space Research Network seed programme, funding collaboration with the University of Technology Sydney on digital optimisation of spacesuit form and fit. A win in the space category at the inaugural SXSW Sydney pitch competition. A memorandum of understanding with Digilogic Systems, an Indian aerospace and defence systems integrator.

SUBSEQUENT RECORD

March 2024: $250,000 Australian Space Agency Moon to Mars grant targeting technology readiness for the Kosmosuit, including dual-use terrestrial applications.

July 2024: Engineering Business of the Year at AusSpace24. August 2024: $2 million pre-seed round. Late 2024: Kernel360 launch and Australian Good Design Award. December 2024: India office opened.

STATUS

Showcase participation is external interest from technical evaluators. It is not a technical certification.

The Human Systems Infrastructure Platform now spans four operating domains, with qualification evidence generated through PROVE.

PLATFORM TODAY

CORE covers hardware and life support. PULSE covers telemetry across five domain variants. PROVE covers test rigs, human surrogates and digital twin prediction.